Inhibitory effects of ZSTK474, a phosphatidylinositol 3-kinase inhibitor, on adjuvant-induced arthritis in rats (original) (raw)
References
Donahue KE, Gartlehner G, Jonas DE, Lux LJ, Thieda P, Jonas BL, Hansen RA, Morgan LC, Lohr KN. Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis. Ann Intern Med. 2008;148:124–34. PubMed Google Scholar
Okkenhaug K, Vanhaesebroeck B. PI3K in lymphocyte development, differentiation and activation. Nat Rev Immunol. 2003;3:317–30. ArticlePubMedCAS Google Scholar
Kong D, Yamori T. Advances in development of phosphatidylinositol 3-kinase inhibitors. Curr Med Chem. 2009;16:2839–54. ArticlePubMedCAS Google Scholar
Okkenhug K, Bilancio A, Emery JL, Vanhaesebroeck B. Phosphoinositide 3-kinase in T cell activation and survival. Biochem Soc Trans. 2004;32:332–5. Article Google Scholar
Rommel C, Camps M, Ji H. PI3Kδ and PI3Kγ: partners in crime in inflammation in rheumatoid arthritis and beyond? Nat Rev Immunol. 2007;7:191–201. ArticlePubMedCAS Google Scholar
Fruman DA. Towards an understanding of isoform specificity in phosphoinositide 3-kinase signaling in lymphocytes. Biochem Soc Trans. 2004;32:315–9. ArticlePubMedCAS Google Scholar
Soond DR, Bjørgo E, Moltu K, Dale VQ, Patton DT, Torgersen KM, Galleway F, Twomey B, Clark J, Gaston JS, Taskén K, Bunyard P, Okkenhaug K. PI3K p110δ regulates T-cell cytokine production during primary and secondary immune responses in mice and humans. Blood. 2010;115:2203–13. ArticlePubMedCAS Google Scholar
Pap T, Franz JK, Hummel KM, Jeisy E, Gay R, Gay S. Activation of synovial fibroblasts in rheumatoid arthritis: lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Arthritis Res. 2000;2:59–64. ArticlePubMedCAS Google Scholar
Zhang HG, Wang Y, Xie JF, Liang X, Liu D, Yang P, Hsu HC, Ray RB, Mountz JD. Regulation of tumor necrosis factor α-mediated apoptosis of rheumatoid arthritis synovial fibroblasts by the protein kinase Akt. Arthritis Rheum. 2001;44:1555–67. ArticlePubMedCAS Google Scholar
Ludikhuize J, de Launay D, Groot D, Smeets TJ, Vinkenoog M, Sanders ME, Tas SW, Tak PP, Reedquist KA. Inhibition of forkhead box class O family member transcription factors in rheumatoid synovial tissue. Arthritis Rheum. 2007;56:2180–91. ArticlePubMedCAS Google Scholar
Miyashita T, Kawakami A, Tamai M, Izumi Y, Mingguo H, Tanaka F, Abiru S, Nakashima K, Iwanaga N, Arateke K, Kamachi M, Arima K, Ida H, Migita K, Origuchi T, Tagashira S, Nishikaku F, Eguchi K. Akt is an endogenous inhibitor toward tumor necrosis factor-related apoptosis inducing ligand-mediated apoptosis in rheumatoid synovial cells. Biochem Biophys Res Commun. 2003;312:397–404. ArticlePubMedCAS Google Scholar
Fishman P, Bar-Yehuda S, Madi L, Rath-Wolfson L, Ochaion A, Cohen S, Baharav E. The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis. Arthritis Res Ther. 2006;8:R33. ArticlePubMed Google Scholar
Wang CR, Shiau AL, Chen SY, Lin LL, Tai MH, Shieh GS, Lin PP, Yo YT, Lee CH, Kuo SM, Liu MF, Jou IM, Yang CY, Shen PC, Lee HL, Wu CL. Amelioration of collagen-induced arthritis in rats by adenovirus-mediated PTEN gene transfer. Arthritis Rheum. 2008;58:1650–6. ArticlePubMedCAS Google Scholar
Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 2000;351:95–105. ArticlePubMedCAS Google Scholar
Brunn GJ, Williams J, Sabers C, Wiederrecht G, Lawrence JC Jr, Abraham RT. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J. 1996;15:5256–67. PubMedCAS Google Scholar
Schultz RM, Merriman RL, Andis SL, Bonjouklian R, Grindey GB, Rutherford PG, Gallegos A, Massey K, Powis G. In vitro and in vivo antitumor activity of the phosphatidylinositol 3-kinase inhibitor wortmannin. Anticancer Res. 1995;15:1135–9. PubMedCAS Google Scholar
Hu L, Zaloudek C, Mills GB, Gray J, Jaffe RB. In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002). Clin Cancer Res. 2000;6:880–6. PubMedCAS Google Scholar
Camps M, Ruckle T, Ji H, Ardissone V, Rintelen F, Shaw J, Ferrandi C, Chabert C, Gillieron C, Francon B, Martin T, Gretener D, Perrin D, Leroy D, Vitte PA, Hirsch E, Wymann MP, Cirillo R, Schwarz MK, Rommel C. Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med. 2005;11:936–43. PubMedCAS Google Scholar
Stangenberg L, Ellson C, Cortez-Retamozo V, Ortiz-Lopez A, Yuan H, Blois J, Smith RA, Yaffe MB, Weissleder R, Benoist C, Mathis D, Josephson L, Mahmood U. Abrogation of antibody-induced arthritis in mice by a self-activating viridin prodrug and association with impaired neutrophil and endothelial cell function. Arthritis Rheum. 2009;60:2314–24. ArticlePubMedCAS Google Scholar
Newbould BB. Role of lymph nodes in adjuvant-induced arthritis in rats. Ann Rheum Dis. 1964;23:392–6. ArticlePubMedCAS Google Scholar
Jacobson PB, Morgan SJ, Wilcox DM, Nguyen P, Ratajczak CA, Carlson RP, Harris RR, Nuss M. A new spin on an old model: in vivo evaluation of disease progression by magnetic resonance imaging with respect to standard inflammatory parameters and histopathology in the adjuvant arthritic rat. Arthritis Rheum. 1999;42:2060–73. ArticlePubMedCAS Google Scholar
Yaguchi S, Fukui Y, Koshimizu I, Yoshimi H, Matsuno T, Gouda H, Hirano S, Yamazaki K, Yamori T. Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor. J Natl Cancer Inst. 2006;98:545–56. ArticlePubMedCAS Google Scholar
Kong D, Yamori T. ZSTK474 is an ATP-competitive inhibitor of class I phosphatidylinositol 3-kinase isoforms. Cancer Sci. 2007;98:1638–42. ArticlePubMedCAS Google Scholar
Kong D, Yamori T. Phosphatidylinositol 3-kinase inhibitors: promising drug candidates for cancer therapy. Cancer Sci. 2008;99:1734–40. ArticlePubMedCAS Google Scholar
Kong D, Yaguchi S, Yamori T. Effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor, on DNA-dependent protein kinase. Biol Pharm Bull. 2009;32:297–300. ArticlePubMedCAS Google Scholar
Kong DX, Yamori T. ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor identified using the JFCR39 drug discovery system. Acta Pharmacol Sin. 2010;31:1189–97. ArticlePubMedCAS Google Scholar
Toyama S, Tamura N, Haruta K, Karakida T, Mori S, Watanabe T, Yamori T, Takasaki Y. Inhibitory effects of ZSTK474, a novel phosphoinositide 3-kinase inhibitor, on osteoclasts and collagen-induced arthritis in mice. Arthritis Res Ther. 2010;12:R92. ArticlePubMed Google Scholar
Sugama T. Ishihara N, Tanaka Y, Takahashi M, Yaguchi S, Watanabe T. Amorphous substance of heterocyclic compounds, solid dispersion and pharmaceutical agent containing same, and method of producing same. WO2009066775. 2009.
Van de Langerijt AG, Volsen SG, Hicks CA, Craig PJ, Billingham ME, Van den Berg WB. Cell migration studies in the adoptive transfer of adjuvant arthritis in the Lewis rat. Immunology. 1994;81:414–9. PubMed Google Scholar
Bush KA, Walker JS, Lee CS, Kirkham BW. Cytokine expression and synovial pathology in the initiation and spontaneous resolution phases of adjuvant arthritis: interleukin-17 expression is upregulated in early disease. Clin Exp Immunol. 2001;123:487–95. ArticlePubMedCAS Google Scholar
Wesch D, Marx S, Kabelitz D. Monocyte-dependent death of freshly isolated T lymphocytes: induction by phorbolester and mitogens and differential effects of catalase. J Immunol. 1998;161:1248–56. PubMedCAS Google Scholar
Wiesenberg I, Van Der Meide PH, Schellekens H, Alkan SS. Suppression and augmentation of rat adjuvant arthritis with monoclonal anti-interferon-gamma antibody. Clin Exp lmmunol. 1989;78:245–9. CAS Google Scholar
Bush KA, Farmer KM, Walker JS, Kirkham BW. Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein. Arthritis Rheum. 2002;46:802–5. ArticlePubMedCAS Google Scholar
Bober LA, Rojas-Triana A, Jackson JV, Leach MW, Manfra D, Narula SK, Grace MJ. Regulatory effects of interleukin-4 and interleukin-10 in human neutrophil function ex vivo and on neutrophil influx in a rat model of arthritis. Arthritis Rheum. 2000;43:2660–7. ArticlePubMedCAS Google Scholar
Carter AB, Monick MM, Hunninghake GW. Both Erk and p38 kinases are necessary for cytokine gene transcription. Am J Respir Cell Mol Biol. 1999;20:751–8. PubMedCAS Google Scholar
Kay JE, Benzie CR, Goodier MR, Wick CJ, Doe SEA. Inhibition of T-lymphocyte activation by the immunosuppressive drug FK506. Immunology. 1989;67:473–7. PubMedCAS Google Scholar
Yaguchi S, Izumisawa Y, Sato M, Nakagane T, Koshimizu I, Sakita K, Kato M, Yoshioka K, Sakato M, Kawashima S. In vitro cytotoxicity of imidazolyl-1,3,5-triazine derivatives. Biol Pharm Bull. 1997;20:698–700. ArticlePubMedCAS Google Scholar
Matsuno T, Karo M, Sasahara H, Watanabe T, Inaba M, Takahashi M, Yaguchi S, Yoshioka K, Sakato M, Kawashima S. Synthesis and antitumor activity of benzimidazolyl-1,3,5-triazine and benzimidazolylpyrimidine derivatives. Chem Pharm Bull (Tokyo).2000;48:1778-81. Google Scholar
Claveau D, Sirinyan M, Guay J, Gordon R, Chan CC, Bureau Y, Riendeau D, Mancini JA. Microsomal prostaglandin E synthase-1 is a major terminal synthase that is selectively up-regulated during cyclooxygenase-2-dependent prostaglandin E2 production in the rat adjuvant-induced arthritis model. J Immunol. 2003;170:4738–44. PubMedCAS Google Scholar
Portanova JP, Zhang Y, Anderson GD, Hauser SD, Masferrer JL, Seibert K, Gregory SA, Isakson PC. Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J Exp Med. 1996;184:883–91. ArticlePubMedCAS Google Scholar
Szekanecz Z, Halloran MM, Volin MV, Woods JM, Strieter RM. Kenneth Haines G III, Kunkel SL, Burdick MD, Koch AE. Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis. Arthritis Rheum. 2000;43:1266–77. ArticlePubMedCAS Google Scholar
Jou S-T, Carpino N, Takahashi Y, Piekorz R, Chao J-R, Carpino N, Wang D, Ihle JN. Essential, nonredundant role for the phosphoinositide 3-kinase p110δ in signaling by the B-cell receptor complex. Mol Cell Biol. 2002;22:8580–91. ArticlePubMedCAS Google Scholar
Yanaba K, Hamaguchi Y, Venturi GM, Douglas A, Steeber DA, St. Clair EW, Thomas F, Tedder TF. B cell depletion delays collagen-induced arthritis in mice: arthritis induction requires synergy between humoral and cell-mediated immunity. J Immunol. 2007;179:1369–80. PubMedCAS Google Scholar
Silverman GJ, Carson DA. Roles of B cells in rheumatoid arthritis. Arthritis Res Ther. 2003;5(Suppl 4):S1–6. ArticlePubMed Google Scholar
Keystone EC. B cells in rheumatoid arthritis: from hypothesis to the clinic. Rheumatology. 2005;44:ii8–12. ArticlePubMedCAS Google Scholar